1Morrow JD, Harris TM, Roberts II LJ. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramification for measurement of eicosanoids [J]. Anal Biochem, 1990,184:1 - 10
2Pratico D. F2- isopmstanes., sensitive and specific noninvasive indices of lipid peroxidation in vivo[J]. Atherosclemsis,1999,147(1) :1 - 10
3Gerald GA. Isoprostanes:Indices of oxidant stress in atherosclerosis [J]. Atherosclerosis, 2000, 151 ( 1 ) : 234 - 238
4Basu S, Nozari A, Liu XL, et al. Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrest[J]. FEBS Letter, 2000,470 : 1 - 6
5Mohammad RM, Cen E, Franz T, et al. Theisoprostane,8 - epi - PGF2α is accumulated in coronary arteries isolated from patients with coronary heart disease[J]. Cardiovascular Research, 1999,43 (2) : 492 - 499
8Romero JC, Reckelhoff JF. Oxidative stress may explain how hypertension is maintained by normal levels of angiotensin[J]. Braz J Med Biol Res,2000,33 (6) ,653 - 660
9Garzetti GG, Tranquilli AL, Cugini AM, et al. Altered lipid composition in creased lipid peroxition and altered fluidity of the membrance of platelet damage in preeclampsial[J]. Obstet Gynecol, 1992,35:317 - 321
10Kunapuli P, Lawson JA, Rokach JA, et al. Prostaglandin F2alpha (PGF2alpha) and the isoprostane, 8,12 - iso- isoprostane F2alpha- Ⅲ,induce cardiomyocyte hypertrophy. Differential activation of downstream signaling pathways [J]. J Biol Chem, 1998,273(35) : 2244 - 2452
3Basu S, Whiteman M, Mattey DL, et al. Raised levels of F(2)- isoprostanes and prostaglandin F (2alpha) in different rheumatic diseases. Ann Rheum Dis, 2001, 60(6): 627-631.
4Marks R, Barton SP, Shuttleworth D, et al. Assessment of disease progress in psoriasis. Arch Dermatol, 1989, 125(2): 235-240.
5Vanizor Kural B, Orem A, Cimsit G, et al. Evaluation of the atherogenie tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis. Clin Chim Acta, 2003, 328 (1-2): 71-82.
6Yildirim M, Inaloz HS, Baysal V, et al. The role of oxidants and antioxidants in psoriasis. J Eur Aead Dermatol Venereol, 2003, 17 ( 1 ): 34-36.
7Baz K, Cimen MY, Kokturk A, et al. Oxidant / antioxidant status in patients with psoriasis. Yonsei Med J, 2003, 44(6): 987-990.
8Kadam DP, Suryakar AN, Ankush RD, et al. Role of oxidative stress in various stages of psoriasis. Indian J Clin Biochem, 2010, 25(4): 388-392.
